ribitol xylosyltransferase 1

Summary
Gene Symbol
  • RXYLT1
Aliases
  • HP10481
Organism
Homo sapiens (human)
NCBI Gene
10329
HGNC
13530
KEGG Gene ID
hsa:10329
PubChem
10329
Alliance of Genome Resources
Annotation
Keyword
  • Congenital muscular dystrophy
  • Disease variant
  • Dystroglycanopathy
  • Golgi apparatus
  • Lissencephaly
  • Reference proteome
  • Signal-anchor
  • Transferase
  • Transmembrane helix
Proteins
Displaying 1 entry
UniProt Protein Name
Q9Y2B1
  • Transmembrane protein 5
  • UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase
Gene Ontology (GO)
Displaying 1 entry
GO Term Evidence Code PMID
protein O-linked mannosylation
GO Hierarchy
OrthoDB (Group)
Group level
Eukaryota
Group Name
ribitol-5-phosphate xylosyltransferase 1
Functional Category
  • E: Amino acid transport and metabolism
  • G: Carbohydrate transport and metabolism
  • T: Signal transduction mechanisms
KEGG BRITE Database
Orthology
K21052
Name
alpha-dystroglycan beta1,4-xylosyltransferase [EC:2.4.2.61]
References
Disease
Disease Ontology
Displaying all 2 entries
DO ID Disease Name Source
DOID:0050560 Walker-Warburg syndrome
DOID:0111239 congenital muscular dystrophy-dystroglycanopathy type A10
The Human Phenotype Ontology
Displaying entries 1 - 10 of 53 in total
HPO ID HPO Term
HP:0000007 Autosomal recessive inheritance
HP:0000028 Cryptorchidism
HP:0000133 Gonadal dysgenesis
HP:0000175 Cleft palate
HP:0000176 Submucous cleft hard palate
HP:0000193 Bifid uvula
HP:0000238 Hydrocephalus
HP:0000252 Microcephaly
HP:0000256 Macrocephaly
HP:0000358 Posteriorly rotated ears
Displaying all 2 entries
Disease ID Disease Name
OMIM:615041
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
ORPHA:899
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
  • muscular dystrophy-dystroglycanopathy, type A

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024